FdaApplication
NDA 021866
Identifiers
- fda_app_no: NDA021866
Properties
| Property | Value |
|---|---|
| applicant_name | OTSUKA PHARMACEUTICAL CO LTD |
| application_type | NDA |
| approval_date | 2006-09-20 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ABILIFY | ARIPIPRAZOLE | 9.75MG/1.3ML (7.5MG/ML) | INJECTABLE;INTRAMUSCULAR |
1 product